Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

Clicks: 502
ID: 118400
1991
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #15 of 62 articles by views in annals of internal medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Cefoperazone and ceftazidime were equally effective when used in combination antibiotic therapy with piperacillin. Twice-daily cefoperazone is less expensive than ceftazidime given three times daily. Monotherapy with imipenem, at a daily dose of 2 g, is as efficacious as double beta-lactam therapy a …
Reference Key
dj1991annalsbeta-lactam Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Winston DJ, Ho WG, Bruckner DA, Champlin RE
Are you one of these authors? Claim your profile
Journal annals of internal medicine
Year 1991
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/1952471
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't adult female male adolescent aged middle aged Comparative Study P.H.S. Clinical Trial Randomized Controlled Trial anti-bacterial agents / adverse effects microbial sensitivity tests agranulocytosis / complications* drug therapy fever / drug therapy* r e champlin bacterial infections / drug therapy* combination / therapeutic use fever / etiology anti-bacterial agents / therapeutic use* costs and cost analysis anti-bacterial agents / economics bacterial infections / etiology fever / microbiology gram-negative bacterial infections / drug therapy gram-positive bacterial infections / drug therapy piperacillin / therapeutic use pmid:1952471 doi:10.7326/0003-4819-115-11-849 d j winston w g ho cefoperazone / therapeutic use ceftazidime / therapeutic use imipenem / therapeutic use superinfection / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.